United States· US:62135-858_22f63e6a-d1c4-1057-e063-6394a90a0721
Hyoscyamine sulfate
A hyoscyamine product containing hyoscyamine sulfate, registered in United States by Chartwell RX, LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Hyoscyamine is registered in 3 of 19 countries.
Countries holding a registration under ATC A03BA03 (hyoscyamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Hyoscyamine · ATC A03BA03
3 / 19 countries
- Finlandprice
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYOSCYAMINE SULFATE
- Manufacturer
- Chartwell RX, LLC
- Country
- United States (US)
- ATC code
- A03BA03
- ATC class
- Hyoscyamine
- Defined daily dose
- 1.2 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162135-858-12
- ndc116213585812120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-858-12)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for hyoscyamine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyoscyamine · interactions on record
217 records
- 6 severe
- 194 moderate
- 17 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hyoscyamine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e707b439-b322-47ef-8576-a8cab59f5e03 GET /v1/drugs/e707b439-b322-47ef-8576-a8cab59f5e03?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".125",
"substance": "HYOSCYAMINE SULFATE",
"productndc": "62135-858",
"dosage_form": "TABLET, ORALLY DISINTEGRATING",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about hyoscyamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.